Alerts will be sent to your verified email
Verify Email
CHEMOPH
|
Starsource Multitrad
|
Ortin Global
|
Norris Medicines
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.45 % | 1.67 % | 25.68 % |
|
5yr average Equity Multiplier
|
1.01 | 2.06 | -1.27 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.28 | 0.6 |
|
5yr Avg Net Profit Margin
|
0.0 | -124.59 % | -27.67 % |
|
Price to Book
|
10.85 | 11.32 | 0.0 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 1016.26 Days | 113.0 Days |
|
Inventory Days
|
0.0 | 326.59 Days | 182.62 Days |
|
Days Receivable
|
0.0 | 1081.4 Days | 77.44 Days |
|
Days Payable
|
0.0 | 645.07 Days | 195.35 Days |
|
5yr Average Interest Coverage Ratio
|
670.55 | -64.13 | -1.07 |
|
5yr Avg ROCE
|
-2.98 % | -34.49 % | -18.91 % |
|
5yr Avg Operating Profit Margin
|
0.0 | -107.87 % | -2.35 % |
|
5 yr average Debt to Equity
|
0.01 | 0.51 | -1.84 |
|
5yr CAGR Net Profit
|
n/a | n/a | -24.21 % |
|
5yr Average Return on Assets
|
-4.07 % | -25.0 % | -17.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.89 % | 1.23 % | 34.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -20.28 % | -0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Starsource Multitrad
|
Ortin Global
|
Norris Medicines
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|